Logo image of NKLA

NIKOLA CORP (NKLA) Stock Fundamental Analysis

NASDAQ:NKLA - Nasdaq - US6541103031 - Common Stock - Currency: USD

0.845  -0.32 (-27.78%)

After market: 0.8419 0 (-0.37%)

Fundamental Rating

2

Overall NKLA gets a fundamental rating of 2 out of 10. We evaluated NKLA against 131 industry peers in the Machinery industry. Both the profitability and financial health of NKLA have multiple concerns. NKLA is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NKLA had negative earnings in the past year.
In the past year NKLA has reported a negative cash flow from operations.
In the past 5 years NKLA reported 4 times negative net income.
NKLA had a negative operating cash flow in each of the past 5 years.
NKLA Yearly Net Income VS EBIT VS OCF VS FCFNKLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M -800M

1.2 Ratios

NKLA has a worse Return On Assets (-61.27%) than 92.13% of its industry peers.
NKLA has a worse Return On Equity (-167.38%) than 89.76% of its industry peers.
Industry RankSector Rank
ROA -61.27%
ROE -167.38%
ROIC N/A
ROA(3y)-69.65%
ROA(5y)-48.86%
ROE(3y)-127.62%
ROE(5y)-84.18%
ROIC(3y)N/A
ROIC(5y)N/A
NKLA Yearly ROA, ROE, ROICNKLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -50 -100

1.3 Margins

NKLA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NKLA Yearly Profit, Operating, Gross MarginsNKLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -100K -200K -300K

More info and screens

2

2. Health

2.1 Basic Checks

NKLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NKLA has less shares outstanding
NKLA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NKLA has been reduced compared to a year ago.
NKLA Yearly Shares OutstandingNKLA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
NKLA Yearly Total Debt VS Total AssetsNKLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

NKLA has an Altman-Z score of -6.29. This is a bad value and indicates that NKLA is not financially healthy and even has some risk of bankruptcy.
NKLA's Altman-Z score of -6.29 is on the low side compared to the rest of the industry. NKLA is outperformed by 91.34% of its industry peers.
A Debt/Equity ratio of 0.72 indicates that NKLA is somewhat dependend on debt financing.
The Debt to Equity ratio of NKLA (0.72) is worse than 73.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z -6.29
ROIC/WACCN/A
WACC4.68%
NKLA Yearly LT Debt VS Equity VS FCFNKLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 500M -500M

2.3 Liquidity

NKLA has a Current Ratio of 1.17. This is a normal value and indicates that NKLA is financially healthy and should not expect problems in meeting its short term obligations.
NKLA has a worse Current ratio (1.17) than 89.76% of its industry peers.
A Quick Ratio of 0.94 indicates that NKLA may have some problems paying its short term obligations.
NKLA's Quick ratio of 0.94 is on the low side compared to the rest of the industry. NKLA is outperformed by 70.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.94
NKLA Yearly Current Assets VS Current LiabilitesNKLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.31% over the past year.
Looking at the last year, NKLA shows a very strong growth in Revenue. The Revenue has grown by 141.23%.
Measured over the past years, NKLA shows a very strong growth in Revenue. The Revenue has been growing by 610.32% on average per year.
EPS 1Y (TTM)66.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.44%
Revenue 1Y (TTM)141.23%
Revenue growth 3Y610.32%
Revenue growth 5YN/A
Sales Q2Q%1553.87%

3.2 Future

NKLA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.89% yearly.
NKLA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 129.36% yearly.
EPS Next Y59.84%
EPS Next 2Y31.61%
EPS Next 3Y21.07%
EPS Next 5Y14.89%
Revenue Next Year188.4%
Revenue Next 2Y177.8%
Revenue Next 3Y151.83%
Revenue Next 5Y129.36%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NKLA Yearly Revenue VS EstimatesNKLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
NKLA Yearly EPS VS EstimatesNKLA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NKLA. In the last year negative earnings were reported.
Also next year NKLA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NKLA Price Earnings VS Forward Price EarningsNKLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NKLA Per share dataNKLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

NKLA's earnings are expected to grow with 21.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.61%
EPS Next 3Y21.07%

More info and screens

0

5. Dividend

5.1 Amount

NKLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NIKOLA CORP

NASDAQ:NKLA (1/23/2025, 9:21:13 PM)

After market: 0.8419 0 (-0.37%)

0.845

-0.32 (-27.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-31 2024-10-31/bmo
Earnings (Next)02-20 2025-02-20/amc
Inst Owners27.97%
Inst Owner Change-0.04%
Ins Owners1.04%
Ins Owner Change0.22%
Market Cap71.38M
Analysts50
Price Target4.08 (382.84%)
Short Float %12.02%
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.31%
Min EPS beat(2)-14.66%
Max EPS beat(2)8.05%
EPS beat(4)3
Avg EPS beat(4)4.83%
Min EPS beat(4)-14.66%
Max EPS beat(4)17.04%
EPS beat(8)6
Avg EPS beat(8)-7.88%
EPS beat(12)10
Avg EPS beat(12)2.84%
EPS beat(16)14
Avg EPS beat(16)10.41%
Revenue beat(2)1
Avg Revenue beat(2)-10.23%
Min Revenue beat(2)-33.69%
Max Revenue beat(2)13.22%
Revenue beat(4)1
Avg Revenue beat(4)-21.12%
Min Revenue beat(4)-53.46%
Max Revenue beat(4)13.22%
Revenue beat(8)1
Avg Revenue beat(8)-37.14%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-27.27%
PT rev (3m)-76.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2292.36%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-24.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-16.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.95
P/FCF N/A
P/OCF N/A
P/B 0.19
P/tB 0.22
EV/EBITDA N/A
EPS(TTM)-11.42
EYN/A
EPS(NY)-6.99
Fwd EYN/A
FCF(TTM)-6.79
FCFYN/A
OCF(TTM)-6.12
OCFYN/A
SpS0.89
BVpS4.49
TBVpS3.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -61.27%
ROE -167.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-69.65%
ROA(5y)-48.86%
ROE(3y)-127.62%
ROE(5y)-84.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 137.76%
Cap/Sales 73.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 0.94
Altman-Z -6.29
F-Score4
WACC4.68%
ROIC/WACCN/A
Cap/Depr(3y)1082.26%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.44%
EPS Next Y59.84%
EPS Next 2Y31.61%
EPS Next 3Y21.07%
EPS Next 5Y14.89%
Revenue 1Y (TTM)141.23%
Revenue growth 3Y610.32%
Revenue growth 5YN/A
Sales Q2Q%1553.87%
Revenue Next Year188.4%
Revenue Next 2Y177.8%
Revenue Next 3Y151.83%
Revenue Next 5Y129.36%
EBIT growth 1Y25.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.66%
EBIT Next 3Y19.66%
EBIT Next 5Y25.05%
FCF growth 1Y21.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.78%
OCF growth 3YN/A
OCF growth 5YN/A